We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for streaming realtime charts, analysis tools, and prices.
| Share Name | Share Symbol | Market | Type |
|---|---|---|---|
| Celgene Corporation | NASDAQ:CELG | NASDAQ | Common Stock |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| 0.00 | 0.00% | 108.24 | 109.30 | 109.44 | 0 | 01:00:00 |
From May 2019 to May 2024
ACHTUNG - KILL : Bitte ignorieren Sie den Text <NJ-CELGENE>, vom <06/04/16>, mit der Überschrift <Gepoolte Daten einer Metaanalyse sprechen für bedeutenden Gesamtüberlebensvorteil durch Prüf-Erhaltungstherapie mit REVLIMID® nach autologer Stammzelltransplantation bei multiplem Myelom>
Originalversion auf businesswire.com ansehen: http://www.businesswire.com/news/home/20160604005081/de/
Celgene:Für Investoren:908-673-9628investors@celgene.comoderfür Medienvertreter:908-673-2275media@celgene.com
1 Year Celgene Chart |
1 Month Celgene Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
